0
Noxopharm Banner Image

Noxopharm

  • Ticker NOX
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Noxopharm Logo Image
  • 11-50 Employees
  • Based in Chatswood, Australia
Noxopharm is an Australian-based clinical-stage drug development company with offices in Sydney and New York. Veyonda is the first pipeline drug candidate which is being trialed as a treatment for a broad range of solid tumor cancers and for septic shock. Later generation drug candidates for large markets of unmet medical need are being developed in an active R&D program.
Noxopharm

Most Recent Annual Report

Noxopharm
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports